Blog - Page 1083 of 5712

ThursdayFeb 03, 2022 11:59 am

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) News Highlighted in Recent NNA Syndicated Broadcast

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements, is the center of attention in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on FuelPositive’s recent filing of its annual audited financial statements for the year ended Sept. 30, 2021, as well as the discussion and analysis provided by company management. NetworkNewsAudio broadcasts are distributed to thousands of syndication points and are designed to deliver additional visibility, recognition and brand awareness in the investment community. “FuelPositive is moving forward at full speed to commercialize our in situ, modular,…

ThursdayFeb 03, 2022 11:28 am

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Strengthens Board with Appointment of Dr. Victoria Hale

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced the appointment of Dr. Victoria Hale to the company’s board of directors. A pharmaceutical scientist, executive and global health social entrepreneur, Dr. Hale currently serves as chair of the board of the Multidisciplinary Association for Psychedelic Studies (“MAPS”). A non-profit research and educational organization, MAPS works to raise awareness of psychedelics and help scientists design, fund and obtain regulatory approval of studies measuring the safety and effectiveness of psychedelics for therapeutic use. “We are thrilled to welcome…

ThursdayFeb 03, 2022 10:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

Cannabicitran is the first of four new rare cannabinoids InMed is planning to launch in the first half of the year to meet growing inbound demand The launch demonstrates InMed’s ability to produce rare cannabinoids at scale, something only very few companies have achieved BayMedica acquisition, other key achievements in 2021, are positioning the company as a leading supplier of rare cannabinoids in the health and wellness sector A leader in the research, development, manufacturing and commercialization of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM) has begun the new year from a more prominent position in the market, following key acquisitions…

ThursdayFeb 03, 2022 9:45 am

SRAX Inc. (NASDAQ: SRAX) Announces Quantity of Shares Repurchased in Q4 2021; Common Stock Dividend Paid in Preferred Shares

SRAX, premier provider of investor intelligence and communications platform, announces the quantity of stock bought-back in Q4 and dividend payment $800K worth of shares was repurchased in Q4 as part of company's $10M stock buy-back program; dividend for common stockholders paid in preferred shares SRAX's corporate action comes amid period of solid growth and robust financial performance SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, announces the number of shares repurchased in the fourth quarter of 2021 and the first payment for the previously issued dividend (https://ibn.fm/lrN26). The repurchase initiative is in…

ThursdayFeb 03, 2022 9:30 am

Plant-based Baby Food Brand’s Rising Profile Boosts Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Prospects

Plant-based food supply chain vertical innovator Eat Well Investment Group Inc. is dedicated to building a supply of more nutritious and tasty foods for international consumers throughout North American markets Majority-owned subsidiary Amara toddler organic food line recently announced it has expanded its presence in H-E-B’s stores throughout Texas since its launch with the retailer last year, including two new plant-based flavors Amara is also being distributed through other big box and e-commerce giants such as Walmart, Amazon and Loblaws Eat Well expects its revenues to grow to $100 million by year’s end The rising profile of baby food brand…

ThursdayFeb 03, 2022 9:15 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Expanding Wellness Clinics’ Reach to Communities Where Access to Life-Changing Mental Health Treatments is Limited

Tens of millions of Americans live in areas where mental health providers are scarce Delic is working on making psychedelic-based treatments more accessible and affordable In 2021, the company acquired Ketamine Infusion Centers (“KIC”) and Ketamine Wellness Centers, becoming the owner and operator of the largest chain of wellness clinics administering ketamine treatments in the U.S. A May 2021 CNBC article exploring the cost and accessibility of mental health care in the United States noted that the number of Americans experiencing depression and anxiety had increased – a total of 42% of U.S. adults had reported symptoms, up from 11%…

ThursdayFeb 03, 2022 9:00 am

InnerScope Hearing Technologies Inc. (INND) Retain CPA Firm Paris, Kreit & Chiu LLP to Audit 2019, 2020, & Q1-Q3 2021 Financials

InnerScope Hearing Technologies revealed that they had retained CPA firm, PKC LLP to perform an independent audit of the company’s 2019, 2020, and 1Q-3Q 2021 results The audited results will be submitted to the SEC and FINRA to establish InnerScope as an SEC fully reporting company InnerScope has recently acquired HearingAssist, a leading direct-to-consumer hearing aid vendor as well as iHear Medical, with the latter providing the company with access to over 40 patents along with an FDA-registered manufacturing and R&D facility InnerScope Hearing Technologies (OTC: INND), a manufacturer and distributer/retailer of DTC, FDA registered, Bluetooth app-controlled hearing aids and…

WednesdayFeb 02, 2022 3:04 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Establishes Enviable Position in Legal Cannabis Market

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is positioned in the growing legal cannabis market, which is expected to see an estimated 16.6% growth in the coming years. “At the beginning of 2021, Sugarmade CEO Jimmy Chan called 2020 a ‘landmark year’ for the company, telling shareholders that in 2021 SGMD would ‘continue to verticalize our model, creating a full farm-to-door structure that expects to produce high-quality branded cannabis products positioned in a vertical in-house supply chain. We expect that this will provide Sugarmade with optimal margins,’” a recent article reads. “The strategy for 2021 appears…

WednesdayFeb 02, 2022 2:56 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Blazing Trail in Defining Value of Rare Cannabinoids in Pharmaceutical Space

InMed Pharmaceuticals (NASDAQ: INM) is a trailblazer, a pioneer defining the value of rare cannabinoids in the pharmaceutical sector and just how integral they are in pushing the industry forward. The global cannabis market is experiencing tremendous growth, particularly considering there are over 100 known cannabinoids, including rare ones that are quickly taking over and will soon dominate the market. The potency of rare cannabinoids has given them powerful health benefits, hence their demand within the cosmetics, food and beverage, health and wellness, and pharmaceutical sectors. “InMed’s most advanced compound, INM-755, has already proven helpful in treating epidermolysis bullosa, a…

WednesdayFeb 02, 2022 2:44 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Laying Robust Foundation for Potentially Pivotal Global Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently received approval from swissethics, the umbrella organization of the cantonal Ethics Committees in Switzerland. The first from a European Ethics Committee, the approval marks a significant milestone for the company as it journeys toward its potentially pivotal study of Berubicin, an anthracycline, for the treatment of Glioblastoma Multiforme (“GBM”). The approval also partly fulfills CNS’s goal of seeing Berubicin approved for the potential treatment of GBM globally. GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. “So far, the company has selected tens of clinical sites across the…

Site Search

Company Search